Transcription of GUIDELINE FOR ORDERING URINE TESTING FOR …
{{id}} {{{paragraph}}}
Page 1 of 9 Guidelines for ORDERING URINE TESTING for Drugs-of- abuse : targeted and screening tests (CLP013) Revised March, 2013 1. Purpose The purpose of this GUIDELINE is to acquaint clinicians with the available laboratory-based URINE TESTING regimens for Drugs-of- abuse (DOA), the most appropriate use and the limitations of this TESTING , and the Ontario Health Insurance Plan (OHIP) reimbursement restrictions for these tests . 2. Background Clinicians screening for an incidental or accidental episode of drug abuse will follow a different protocol than that of clinicians with caseloads that include habitual abusers of multiple drugs, or who are monitoring patients for adherence to a treatment program.
Page 1 of 9 Guidelines for Ordering Urine Testing for Drugs-of-Abuse: Targeted and Screening Tests (CLP013) Revised March, 2013
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
Drug Testing, Clinical, Clinical Practice Guidelines for Prenatal Laboratory, Guidelines for Prenatal Laboratory Screening, Testing, Screening, Workplace Drug and Alcohol Testing Laws, Local Coverage Determination for Qualitative Drug, Drug, QuickScreen, Drug Screening, What Your Drug Test Really Means